$HIND
Vyome Holdings, Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · San Clemente, CA
HIND chart
What traders are saying about $HIND
Latest postsVyome Holdings, Inc news
- Trading (HIND) With Integrated Risk Controls (HIND:CA)
Stock Traders Daily ·
- Vyome Co-Founder Shiladitya Sengupta Promoted to Professor at Harvard Medical School
citybiz ·
- Vyome Co-Founder Dr. Shiladitya Sengupta Promoted to Professor at Harvard Medical School
Yahoo Finance ·
- Vyome Holdings, Inc. Estimates – NASDAQ:HIND
TradingView ·
- Vyome Receives USPTO Notice of Allowance for U.S. Patent Covering VT-1908, its Novel Topical Mycophenolate Program Targeting the $20+ Billion Ocular Inflammation Market
Yahoo Finance ·
- Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
Yahoo Finance ·
- Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet
Yahoo Finance ·
- Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
Yahoo Finance ·
- Vyome Holdings Inc (HIND) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
Yahoo Finance ·
- We're Not Very Worried About Vyome Holdings' (NASDAQ:HIND) Cash Burn Rate
Yahoo Finance ·
Vyome Holdings, Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | $8.0M | $8.7M | $11.2M |
| Net income | -$10.3M | -$1.4M | -$11.4M | -$46.2M |
| Diluted EPS | $-4.86 | $-6001.39 | $-110.87 | $-108.90 |
| Total assets (year end) | $6.5M | $1.4M | $10.7M | $11.1M |
| Cash and equivalents (year end) | $5.0M | $101,904 | $4.5M | $3.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- DEF 14APROXY STATEMENT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
About Vyome Holdings, Inc
- Ticker
- HIND (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Clemente, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1427570
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Frequently asked questions
What exchange is Vyome Holdings, Inc listed on?
Vyome Holdings, Inc trades on the Nasdaq under the ticker symbol HIND.
What industry is Vyome Holdings, Inc in?
Vyome Holdings, Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Vyome Holdings, Inc headquartered?
Vyome Holdings, Inc's business address on file with the SEC is in San Clemente, CA.
When does Vyome Holdings, Inc's fiscal year end?
Vyome Holdings, Inc's fiscal year ends on December 31.
How much revenue did Vyome Holdings, Inc report?
Vyome Holdings, Inc reported $8.0M in revenue for calendar year 2024, according to its SEC filings.